SINGAPORE (Feb 26): Analysts are generally neutral on Raffles Medical Group (RMG) after the group yesterday announced that its FY18 earnings saw a slight 0.4% increase y-o-y to $71.1 million, while revenue grew 2.4% to $489.1 million.
The group is also recommending a final dividend of 2 cents per share.
See: Raffles Medical posts 0.4% rise in FY18 earnings to $71.1 mil; recommends 2 cents final dividend
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)